NCT03447197

Brief Summary

Randomised controlled trials (RCTs) have shown high long-term patency for no-touch saphenous vein grafts (NTSVGs), comparable to the internal thoracic artery in on-pump coronary artery bypass grafting (CABG). RCTs on patency in NTSVGs in off-pump CABG have not been published yet. Orebro University Hospital participated in the CABG Off- or On-pump Revascularization study (CORONARY, ClinicalTrials.gov number, NCT00463294) and included fifty-six patients. Accordingly, this is a sub-study and the aim was to assess the midterm patency in NTSVGs in clamp-less off-pump versus on-pump CABG at five-year follow-up.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
59

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2015

Typical duration for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2015

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2016

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2017

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 20, 2018

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 27, 2018

Completed
Last Updated

February 27, 2018

Status Verified

February 1, 2018

Enrollment Period

1.3 years

First QC Date

February 20, 2018

Last Update Submit

February 25, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Graft patency

    Graft patency as assessed with computed tomography angiography

    Five years postoperatively

Study Arms (2)

On-Pump

ACTIVE COMPARATOR

Use of extracorporeal circulation

Procedure: The use of extracorporeal circulation

Off-Pump

NO INTERVENTION

Interventions

The use or not of extracorporeal circulation during the coronary artery bypass procedure.

On-Pump

Eligibility Criteria

Age55 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients were eligible if they:
  • provided written informed consent;
  • were \>21 years of age;
  • required isolated CABG with median sternotomy;
  • had at least one of the following risk factors:
  • had peripheral vascular disease (previous peripheral bypass, amputation or anklebranchial index \<0.90),
  • had cerebrovascular disease (history of stroke, transient ischemic attach or carotid stenosis ≥70%),
  • had renal insufficiency (creatinine above upper limit of normal),
  • were ≥70 years of age, or
  • were between the ages of 60-69 with one of the following: i. had diabetes and taking an oral hypoglycemic agent and/or insulin, ii. required urgent revascularization (i.e., waiting in hospital for revascularization after an acute coronary syndrome), iii. were a recent smoker (within 1 year of randomization), or iv. had left ventricular ejection fraction ≤35%, OR
  • were between the ages of 55-59 with two of the following: i. Diabetes and taking an oral hypoglycemic agent and/or insulin, ii. required urgent revascularization (i.e., waiting in hospital for revascularization after an acute coronary syndrome, iii. were a recent smoker (within 1 year of randomization), or iv. had a left ventricular ejection fraction ≤35%

You may not qualify if:

  • Patients were excluded if they:
  • required a concomitant cardiac procedure associated with CABG;
  • had a contraindication to off-pump or on-pump CABG (e.g., calcified aorta, intramuscular left anterior descending artery, calcified coronaries, small target vessels);
  • had a concomitant life-threatening disease likely to limit life expectancy to less than 2 years;
  • were previously enrollment in the CORONARY Trial;
  • required emergency CABG surgery (i.e., immediate revascularization for hemodynamic instability); OR
  • required a redo CABG.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Coronary Stenosis

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Consultant in Cardiothoracic Surgery

Study Record Dates

First Submitted

February 20, 2018

First Posted

February 27, 2018

Study Start

September 1, 2015

Primary Completion

December 31, 2016

Study Completion

December 31, 2017

Last Updated

February 27, 2018

Record last verified: 2018-02